GESTIÓN EN SALUD PÚBLICA: Public Meeting on the Recommendations for Biosimilar User Fee Act (BsUFA) Reauthorization - 11/02/2021 - 11/02/2021 | FDA

miércoles, 22 de septiembre de 2021

Public Meeting on the Recommendations for Biosimilar User Fee Act (BsUFA) Reauthorization - 11/02/2021 - 11/02/2021 | FDA

Public Meeting on the Recommendations for Biosimilar User Fee Act (BsUFA) Reauthorization - 11/02/2021 - 11/02/2021 | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)